BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29330402)

  • 1. Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria.
    Hayashi H; Ruggeri A; Volt F; Cornelissen JJ; Socié G; Sengeloev H; Michallet M; Karakasis D; Petersen E; Cahn JY; Veelken H; Mercier M; Rohrlich PS; Rafii H; Kenzey C; Xavier E; Duarte RF; Basak GW; Rocha V; Gluckman E;
    Bone Marrow Transplant; 2018 Apr; 53(4):417-421. PubMed ID: 29330402
    [No Abstract]   [Full Text] [Related]  

  • 2. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
    Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation.
    Inagaki J; Moritake H; Nishikawa T; Hyakuna N; Okada M; Suenobu S; Nagai K; Honda Y; Shimomura M; Fukano R; Noguchi M; Kurauchi K; Tanioka S; Okamura J
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1973-80. PubMed ID: 26234723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral manifestations compatible with chronic graft-versus-host disease in patients with Fanconi anemia.
    Grein Cavalcanti L; Fuentes Araújo RL; Bonfim C; Torres-Pereira CC
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):275-80. PubMed ID: 25316110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria.
    Sato T; Ichinohe T; Kanda J; Yamashita K; Kondo T; Ishikawa T; Uchiyama T; Takaori-Kondo A
    Int J Hematol; 2011 Apr; 93(4):532-541. PubMed ID: 21465116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients.
    Kerep AZ; Broome J; Pirsl F; Curtis LM; Steinberg SM; Mitchell SA; Cowen EW; Pichard DC; Joe GO; Comis LE; Mays JW; Datiles MB; Stratton P; Zolton J; Berger A; Hendricks J; Kenyon M; Baruffaldi J; Titarenko I; Pulanic D; Baird K; Fowler DH; Gress RE; Pavletic SZ
    Bone Marrow Transplant; 2019 Jan; 54(1):76-84. PubMed ID: 30089900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response and survival of patients with chronic graft-versus-host disease treated by extracorporeal photochemotherapy: a retrospective study according to classical and National Institutes of Health classifications.
    Del Fante C; Scudeller L; Viarengo G; Bernasconi P; Perotti C
    Transfusion; 2012 Sep; 52(9):2007-15. PubMed ID: 22320219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.
    Baird K; Steinberg SM; Grkovic L; Pulanic D; Cowen EW; Mitchell SA; Williams KM; Datiles MB; Bishop R; Bassim CW; Mays JW; Edwards D; Cole K; Avila DN; Taylor T; Urban A; Joe GO; Comis LE; Berger A; Stratton P; Zhang D; Shelhamer JH; Gea-Banacloche JC; Sportes C; Fowler DH; Gress RE; Pavletic SZ
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):632-9. PubMed ID: 23340040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
    Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria.
    Jagasia M; Giglia J; Chinratanalab W; Dixon S; Chen H; Frangoul H; Engelhardt B; Goodman S; Greer J; Kassim A; Morgan D; Ruffner K; Schuening F
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1207-15. PubMed ID: 17889358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of NIH consensus criteria for chronic graft-versus-host disease.
    Cho BS; Min CK; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Kim CC
    Leukemia; 2009 Jan; 23(1):78-84. PubMed ID: 18830253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NIH consensus criteria for chronic graft-versus-host disease: far more than just another classification.
    Socié G
    Leukemia; 2009 Jan; 23(1):1-2. PubMed ID: 19142188
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis and staging of chronic graft-versus-host disease in the clinical practice.
    Greinix HT; Loddenkemper C; Pavletic SZ; Holler E; Socié G; Lawitschka A; Halter J; Wolff D
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):167-75. PubMed ID: 20691801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reevaluation of the National Institutes of Health criteria for classification and scoring of chronic GVHD.
    Kim DY; Lee JH; Lee JH; Kim SH; Lim SN; Kim SD; Choi Y; Lee YS; Kang YA; Kang SI; Seol M; Ryu SG; Lee KH
    Bone Marrow Transplant; 2010 Jul; 45(7):1174-80. PubMed ID: 19915630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.
    Mitchell SA; Jacobsohn D; Thormann Powers KE; Carpenter PA; Flowers ME; Cowen EW; Schubert M; Turner ML; Lee SJ; Martin P; Bishop MR; Baird K; Bolaños-Meade J; Boyd K; Fall-Dickson JM; Gerber LH; Guadagnini JP; Imanguli M; Krumlauf MC; Lawley L; Li L; Reeve BB; Clayton JA; Vogelsang GB; Pavletic SZ
    Biol Blood Marrow Transplant; 2011 Nov; 17(11):1619-29. PubMed ID: 21536143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severity.
    Aki SZ; Inamoto Y; Carpenter PA; Storer BE; Sandmaier BM; Lee SJ; Martin PJ; Flowers ME
    Bone Marrow Transplant; 2016 Oct; 51(10):1350-1353. PubMed ID: 27214071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic graft versus host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantation.
    Gutman JA; Ross K; Smith C; Myint H; Lee CK; Salit R; Milano F; Delaney C; Gao D; Pollyea DA
    Bone Marrow Transplant; 2016 Dec; 51(12):1588-1593. PubMed ID: 27400068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verification of the new grading scale for ocular chronic graft-versus-host disease developed by the German-Austrian-Swiss consensus conference on chronic GVHD.
    Blecha C; Wolff D; Holler B; Holler E; Weber D; Vogt R; Helbig H; Dietrich-Ntoukas T
    Ann Hematol; 2016 Feb; 95(3):493-9. PubMed ID: 26659079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathologic diagnosis of chronic graft-versus-host disease of the oral mucosa according to the National Institutes of Health Consensus.
    Santos PS; Coracin FL; Barros JC; Gallottini MH
    Einstein (Sao Paulo); 2014 Apr; 12(2):204-10. PubMed ID: 25003927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of NIH consensus criteria for diagnosis and severity-grading of chronic graft-versus-host disease.
    Aisa Y; Mori T; Kato J; Yamane A; Kohashi S; Kikuchi T; Okamoto S
    Int J Hematol; 2013 Feb; 97(2):263-71. PubMed ID: 23371545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.